BioVie Inc. announced the appointment of Mr. James Lang as an independent member of the company's Board of Directors. Mr. Lang is an active investor in emerging healthcare companies, and recently invested in BioVie. Mr. Lang was formerly the Chief Executive Officer of Decision Resources Group. During his tenure there, Mr. Lang helped achieving robust revenue and profit growth. Previously Mr. Lang was the CEO of Strategic Decisions Group, where he expanded the life sciences practice and later sold it to IMS Health. He brings a highly relevant experience base, having invested in and guided the development of multiple early-stage healthcare companies including Boston Heart Diagnostics, which sold for $140 million, and AlphalmpactRx, which sold to IMS health earlier this year.